150 related articles for article (PubMed ID: 34436036)
1. Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada.
O'Sullivan DE; Cheung WY; Syed IA; Moldaver D; Shanahan MK; Bebb DG; Sit C; Brenner DR; Boyne DJ
Curr Oncol; 2021 Aug; 28(4):3091-3103. PubMed ID: 34436036
[TBL] [Abstract][Full Text] [Related]
2. Real-world utilization of immune checkpoint inhibitors in extensive stage small-cell lung cancer in community settings.
Zu K; Arunachalam A; Hohlbauch A; Silver M; Robert N
Immunotherapy; 2023 Nov; 15(16):1375-1387. PubMed ID: 37694560
[TBL] [Abstract][Full Text] [Related]
3. Adoption of prophylactic cranial irradiation (PCI) for extensive stage small cell lung cancer (ES-SCLC): a population based outcome study.
Soon YY; Zheng H; Ho SZ; Koh WY; Leong CN; Tey JCS; Vellayappan B; Yap SP; Tham IWK; Fong KW
Radiat Oncol; 2018 Dec; 13(1):247. PubMed ID: 30547818
[TBL] [Abstract][Full Text] [Related]
4. Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer.
Elegbede AA; Gibson AJ; Fu H; Dean ML; Ezeife DA; Lau H; Cheung WY; Bebb DG
Am J Clin Oncol; 2020 Apr; 43(4):236-242. PubMed ID: 31842113
[TBL] [Abstract][Full Text] [Related]
5. Small-cell Lung Cancer in Very Elderly (≥ 80 Years) Patients.
Schild SE; Zhao L; Wampfler JA; Daniels TB; Sio T; Ross HJ; Paripati H; Marks RS; Yi J; Liu H; He Y; Yang P
Clin Lung Cancer; 2019 Jul; 20(4):313-321. PubMed ID: 31155475
[TBL] [Abstract][Full Text] [Related]
6. Survival and prognostic factors in elderly patients receiving second-line chemotherapy for relapsed small-cell lung cancer: Results from the Japanese Joint Committee of Lung Cancer Registry.
Igawa S; Naoki K; Shintani Y; Sekine I; Shukuya T; Takayama K; Inoue A; Okamoto I; Kiura K; Takahashi K; Yamamoto N; Takiguchi Y; Miyaoka E; Okumura M; Yoshino I
Lung Cancer; 2020 Aug; 146():160-164. PubMed ID: 32540559
[TBL] [Abstract][Full Text] [Related]
7. Survival, Chemotherapy Treatments, and Health Care Utilization Among Patients with Advanced Small Cell Lung Cancer: An Observational Study.
He J; Shao C; Hui SL; Zhang Z; Baker J; Dexter PR; Kachroo S; Jin F
Adv Ther; 2020 Jan; 37(1):552-565. PubMed ID: 31828610
[TBL] [Abstract][Full Text] [Related]
8. Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data study.
Huang J; Faisal W; Brand M; Smith S; Alexander M; Briggs L; Conron M; Duffy M; John T; Langton D; Lesage J; MacManus M; Mitchell P; Olesen I; Parente P; Philip J; Samuel E; Torres J; Underhill CR; Zalcberg JR; Harden S; Stirling R
Med J Aust; 2023 Aug; 219(3):120-126. PubMed ID: 37365486
[TBL] [Abstract][Full Text] [Related]
9. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
[TBL] [Abstract][Full Text] [Related]
10. Real-world treatment patterns and outcomes of patients with small cell lung cancer progressing after 2 lines of therapy.
Coutinho AD; Shah M; Lunacsek OE; Eaddy M; Willey JP
Lung Cancer; 2019 Jan; 127():53-58. PubMed ID: 30642551
[TBL] [Abstract][Full Text] [Related]
11. Survival of patients with small cell lung carcinoma in Taiwan.
Kuo YH; Lin ZZ; Yang YY; Shao YY; Shau WY; Kuo RN; Yang JC; Lai MS
Oncology; 2012; 82(1):19-24. PubMed ID: 22269348
[TBL] [Abstract][Full Text] [Related]
12. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
[TBL] [Abstract][Full Text] [Related]
13. Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy.
Goldschmidt J; Hart L; Scott J; Boykin K; Bailey R; Heritage T; Lopez-Gonzalez L; Zhou ZY; Edwards ML; Monnette A; Ogbonnaya A; Deyoung K; Venkatasetty D; Shi P; Aton L; Huang H; Conkling PR; Gordan L
Adv Ther; 2023 Oct; 40(10):4189-4215. PubMed ID: 37490258
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy versus best supportive care for extensive small cell lung cancer.
Pelayo Alvarez M; Westeel V; Cortés-Jofré M; Bonfill Cosp X
Cochrane Database Syst Rev; 2013 Nov; (11):CD001990. PubMed ID: 24282143
[TBL] [Abstract][Full Text] [Related]
15. Influence of VEGFR2 gene polymorphism on the clinical outcomes of apatinib for patients with chemotherapy-refractory extensive-stage SCLC: a real-world retrospective study.
Geng N; Ding CM; Liu ZK; Song S; Hu WX
Int J Clin Oncol; 2021 Apr; 26(4):670-683. PubMed ID: 33392882
[TBL] [Abstract][Full Text] [Related]
16. Small cell lung cancer in the young: Characteristics, diagnosis and outcome data.
Jiang S; Hao X; Li J; Hu X; Xiao Z; Wang H; Wang Y; Sun Y; Shi Y
Clin Respir J; 2019 Feb; 13(2):98-104. PubMed ID: 30586232
[TBL] [Abstract][Full Text] [Related]
17. Treatment patterns and clinical outcomes in 157 patients with extensive-stage small cell lung cancer: real-world evidence from a single-center retrospective study.
Zheng Y; Tan K; Wang A; Lu X; Dong H; Li J; Cui H
Front Oncol; 2023; 13():1287628. PubMed ID: 38111524
[TBL] [Abstract][Full Text] [Related]
18. Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes.
Moser SS; Bar J; Kan I; Ofek K; Cohen R; Khandelwal N; Shalev V; Chodick G; Siegelmann-Danieli N
Curr Oncol; 2021 Jan; 28(1):317-331. PubMed ID: 33435584
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
[TBL] [Abstract][Full Text] [Related]
20. Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer.
Rittberg R; Leung B; Al-Hashami Z; Ho C
Front Oncol; 2022; 12():1002385. PubMed ID: 36185266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
